Pharma manufacturers in the future will reimburse payers on payments for ineffective therapies based on outcomes.
John Meehan, PharmD, MSPBA
Advertisement
Articles by John Meehan, PharmD, MSPBA
Specialty pharmacies are poised to fill a need in health care should the use of Health Savings Accounts grow.
Advertisement
Latest Updated Articles
Specialty Pharmacy and the Future of the ACAMarch 6th 2017
Advertisement
Advertisement
Trending on Pharmacy Times
1
mRNA COVID-19 Booster Outperforms Protein-Based Shot on Antibodies, But Both Cut Infections Over 12 Months
2
Navigating REMS: Challenges, Perspectives, and the Path Forward for Bispecific Antibody Programs
3
FDA Approves Zidesamtinib for Previously Treated ROS1-Positive NSCLC
4
Building a Pharmacist-Led Furoscix Workflow From Scratch
5